Use of enzymes with a wide pH activity range as medicaments for promoting digestion
Disclosed is a combination of two or more lipase enzymes, and its use for treating a lipid digestion deficiency and/or a digestive disorder. At least one lipase enzyme has a pH optimum at an acidic pH value, while at least one other lipase enzyme has a pH optimum at an alkalic pH value.
1. A method of treating a lipid digestion deficiency in a subject, the method comprising administering a combination of two or more lipase enzymes to the subject, wherein at least one of the two or more lipase enzymes has a pH optimum at a pH value in the range of ≥1 and ≤6 and wherein the second lipase enzyme has a pH optimum at a pH value in the range of ≥8 and ≤11.
2. The method of claim 1 , wherein the lipid digestion deficiency is exocrine pancreatic insufficiency.
3. The method of claim 1 , wherein the at least one of the two or more lipase enzymes has lipolytic activity that is determined by a Nixon Test or a titration test.
4. The method of claim 1 , wherein the at least one of the two or more lipase enzymes is a lipase enzyme encoded, expressed and/or produced by an organism of order of ciliates.
5. The method of claim 4 , wherein the lipase enzyme has been modified by site directed or random mutagenesis and subsequent selection.
6. The method of claim 1 , wherein at least one of the two or more lipase enzymes has a pH optimum at an acidic pH value which occurs in the stomach of a mammal and wherein the second lipase enzyme has a pH optimum at an alkali alkaline pH which occurs in the lower small intestine of a mammal.
7. The method of claim 1 , wherein the two or more lipase enzymes comprise an amino acid sequence selected from the group consisting of SEQ ID NOs: 4, 5, or 6, fractions, variants, homologues or derivatives thereof; an amino acid sequence having a sequence identity of at least 70% with SEQ ID NOs: 4, 5 or 6; or an amino acid sequence having a sequence identity of at least 95% with SEQ ID NOs: 4, 5 or 6.